Last reviewed · How we verify
NCT05095792
Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
trial testing Observational - no intervention in Treatment-resistant Depression in 1 participant. Terminated before completion.
21 October 2022
Quick facts
| Lead sponsor | Entheon Biomedical Corp. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 9 November 2021 |
| Primary completion | 21 October 2022 |
| Estimated completion | 21 October 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Observational - no intervention
Conditions studied
- Treatment-resistant Depression — all drugs for Treatment-resistant Depression →
Sponsor
Entheon Biomedical Corp.
Who can join
Adults 21 to 60, any sex, with Treatment-resistant Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study will allow data to be collected to demonstrate changes in brain activity following administration of standard of care (SOC) Ketamine. By comparing genetic markers across participants, data on impact of genetic markers and response to Ketamine will also be analysed. This data will contribute to the design of future studies utilizing Ketamine for various psychiatric disorders. This study will focus on treatment-resistant Major Depressive Disorder (MDD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05095792
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observational - no intervention
Trials testing the same drug.
- NCT06907953 — CZI Rare As One: Co-designing an App and Wearable Based Compass for Rare Diseases · completed
- NCT02573779 — Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk · completed
Other recruiting trials for Treatment-resistant Depression
Currently open trials in the same condition.
- NCT05661383 — Olfactory and Brain Stimulations in Treatment-resistant Depression · NA · recruiting
- NCT05607654 — The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression · NA · recruiting
- NCT05377177 — Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst St · NA · recruiting
- NCT04680910 — Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) I · Phase 1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05095792 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Entheon Biomedical Corp.
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05095792.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing